Table 3.

Demographic, fluids and outcome variables in liver transplant patients grouped by ICU length of stay

	<5 days ICU stay (n = 78)	≥5 days ICU stay (n = 80)	P value
Male gender	25 (32%)	41 (51.2%)	0.015
HCC	33 (42.3%)	19 (23.1.7%)	0.014
Pretransplant MELD score	17 ± 5.9	21.3 ± 8	0.001
Volume of crystalloids received by 72 hours ml (IQR)	1,675 (1,055)	1,520 (1,066)	0.034
Volume of colloids received by ml (IQR)
24 hours posttransplant	1,247 (1,263)	1,700 (1,188)	0.046
48 hours posttransplant	650 (713)	950 (1095)	0.015
Undrained pleural effusion posttransplant	28 (35.8%)	50 (62.5%)	0.001
Vasopressors requirement
48 hours posttransplant	8 (10.3%)	28 (35%)	0.001
72 hours posttransplant	2 (2.6%)	10 (12.5%)	0.031
AKI	17 (22%)	40 (50%)	<0.001
Early complications	43 (55.1%)	50 (62.5%)	0.035

AKI, acute kidney injury; HCC, hepatocellular carcinoma; ICU, intensive care unit; IQR, interquartile range; MELD, model for end-stage liver disease.